Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for immune-mediated cerebellar ataxia.
7 publications have been identified in PubMed for immune-mediated cerebellar ataxia. Research spans Case Report / Case Series (57%), Review / Meta-Analysis (29%), and Epidemiology / Natural History (14%).
Kimura A (2026). [PMID: 41564469](https://pubmed.ncbi.nlm.nih.gov/41564469/). *J Neuroimmunol*. [Case Report / Case Series]
Choi EH (2025). [PMID: 40186817](https://pubmed.ncbi.nlm.nih.gov/40186817/). *Cerebellum*. [Case Report / Case Series]
Yamada K (2025). [PMID: 40760473](https://pubmed.ncbi.nlm.nih.gov/40760473/). *BMC Neurol*. [Case Report / Case Series]
Maria G (2025). [PMID: 41300630](https://pubmed.ncbi.nlm.nih.gov/41300630/). *Children (Basel)*. [Review / Meta-Analysis]
Erdlenbruch F (2025). [PMID: 41450530](https://pubmed.ncbi.nlm.nih.gov/41450530/). *BMJ Neurol Open*. [Review / Meta-Analysis]
Li M (2024). [PMID: 39877367](https://pubmed.ncbi.nlm.nih.gov/39877367/). *Front Immunol*. [Case Report / Case Series]
Jesse S (2024). [PMID: 39735552](https://pubmed.ncbi.nlm.nih.gov/39735552/). *Front Immunol*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center